$HALO News Amazon gains on June event; PVH sinks on

New Post Public Reply Private Reply Replies (0) Message Board

Sep 18, 2014 at 11:56 AM

$HALO News

Amazon gains on June event; PVH sinks on results 3:36 p.m. June 5, 2014 - Sue Chang
Stock futures rise after ECB moves, claims report 9:00 a.m. June 5, 2014 - Barbara Kollmeyer
ECB, jobs report could finally ignite the stock-market powder keg 8:46 a.m. June 5, 2014 - Shawn Langlois
PVH falls, Halozyme, Five Below, gain after hours 4:51 p.m. June 4, 2014 - Myra P. Saefong
Rackspace shares surge after hours on earnings 6:10 p.m. May 12, 2014 - Wallace Witkowski
Halozyme temporarily halts dosing in cancer study 9:27 a.m. April 4, 2014 - MarketWatch.com
A Morgan Stanley buy, Alcoa's report and the streaker opens up 8:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 12:40 p.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 11:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 6:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 2:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 6:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 2:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 4:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 1:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 11:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 8:30 a.m. Sept. 21, 2012 - MarketWatch.com
Halozyme rebounds 12% in midday trading 11:21 a.m. Aug. 3, 2012 - Val Brickates Kennedy
Halozyme rebounds 10% in morning action 10:52 a.m. Aug. 3, 2012 - Val Brickates Kennedy

Halozyme Therapeutics (HALO) Jumps: Stock Up 9.3% - Tale of the Tape 9:39 a.m. Today - Zacks.com
Halozyme Announces SWOG Will Resume Clinical Trial of PEGPH20 In Combo with Modified FOLFIRINOX for Advanced Pancreatic Cancer 8:04 a.m. Today - benzinga.com
InsiderInsights.com Daily Round Up 9/17/14: HTWR, REGN, IO, HALO 11:01 a.m. Sept. 17, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – AUXL SLXP ENDP HALO 8:45 a.m. Sept. 17, 2014 - InvestorPlace.com
Recent Price Decline Creates An Attractive Entry Point For Halozyme 10:35 a.m. Sept. 16, 2014 - Seeking Alpha
Baxter and Halozyme Therapeutics Get FDA Approval - Analyst Blog 1:50 p.m. Sept. 15, 2014 - Zacks.com
Halozyme Is Worth Betting On 12:02 p.m. Sept. 15, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – AVNR PTCT AZN HALO 8:30 a.m. Sept. 15, 2014 - InvestorPlace.com
Benzinga's Top #PreMarket Gainers 7:06 a.m. Sept. 15, 2014 - benzinga.com
FDA gives thumbs up to Hyqvia 1:26 p.m. Sept. 13, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ISIS PBYI KERX HALO 1:30 p.m. Sept. 11, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – LCI ANAC HALO IRWD 2:00 p.m. Sept. 10, 2014 - InvestorPlace.com
Why You Shouldn't Bet Against Halozyme Therapeutics (HALO) Stock - Tale of the Tape 8:42 a.m. Sept. 8, 2014 - Zacks.com
Halozyme's PEGPH20 Program Gains Fast Track Designation - Analyst Blog 5:00 p.m. Sept. 5, 2014 - Zacks.com
Hottest Healthcare Stocks Now – EXAS ACHN HALO CLDX 9:00 a.m. Sept. 3, 2014 - InvestorPlace.com
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 7:35 a.m. Sept. 3, 2014 - benzinga.com
Halozyme Gains on Narrower-than-Expected Loss, Revenues Up - Analyst Blog 10:53 a.m. Aug. 14, 2014 - Zacks.com
Halozyme Therapeutics' (HALO) CEO Helen Torley on Q2 2014 Results - Earnings Call Transcript 6:50 p.m. Aug. 11, 2014 - Seeking Alpha
10-Q: HALOZYME THERAPEUTICS INC 4:32 p.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biggest Movers in Healthcare Stocks Now – IRWD IPXL SGEN PCRX 7:30 a.m. Aug. 6, 2014 - InvestorPlace.com

SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 9:00 a.m. Today - PR Newswire - PRF
Biotech Stocks in Motion - XOMA, Nanosphere, Isis Pharma, Halozyme Therapeutics, and Synta Pharma 8:45 a.m. Sept. 17, 2014 - PR Newswire - PRF
FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency 7:02 p.m. Sept. 12, 2014 - BusinessWire - BZX
Halozyme's PEGPH20 Program In Metastatic Pancreatic Cancer Receives Fast Track Designation 8:30 a.m. Sept. 3, 2014 - PR Newswire - PRF
Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Pharma, Synta Pharma, Halozyme Therapeutics, and Isis Pharma 9:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Halozyme to Host second Quarter 2014 Financial Results Conference Call 4:30 p.m. Aug. 4, 2014 - PR Newswire - PRF
FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency 1:55 p.m. July 31, 2014 - BusinessWire - BZX
Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 9:00 a.m. July 22, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 7:20 a.m. July 10, 2014 - PR Newswire - PRF
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health 6:20 a.m. July 2, 2014 - PR Newswire - PRF
Roche's Commercial Launch Of MabThera SC Triggers Milestone Payment To Halozyme 8:00 a.m. June 25, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The JMP Securities 2014 Healthcare Conference 4:30 p.m. June 17, 2014 - PR Newswire - PRF
Halozyme Announces Presentation Of Clinical Data At The American Diabetes Association 74th Scientific Sessions 3:00 p.m. June 15, 2014 - PR Newswire - PRF
Biotech Equities under the Scanner -- Research on Halozyme Therapeutics, Medivation, Achillion Pharma, and Alexion Pharma 8:10 a.m. June 6, 2014 - PR Newswire - PRF
Halozyme To Resume PEGPH20 Clinical Program In Pancreatic Cancer 4:05 p.m. June 4, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Jefferies 2014 Global Health Care Conference 4:30 p.m. May 29, 2014 - PR Newswire - PRF
Baxter Provides U.S. Regulatory Update on HyQvia,Its Investigational Subcutaneous Treatment for Primary Immunodeficiency 9:02 a.m. May 21, 2014 - BusinessWire - BZX
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The UBS 2014 Global Health Care Conference 6:00 p.m. May 14, 2014 - PR Newswire - PRF
Top Gainers Pre-Market Notes -- Research on Halozyme Therapeutics, Goodrich Petroleum, BioCryst Pharma, and Coronado Biosciences 12:22 p.m. May 14, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Egan-Jones CLO Metrics Strong Amid Rate Hikes

Interest Rates Climb, CLO Metrics Hold Firm Buckle up, folks. As interest rates drift higher like a stubborn balloon, investors are scouring the landscape for any sign of a shaky foundation. Well, here's a bit of solace in the storm: Egan-Jones, the credit rating powerhouse, has released their latest musings on the collateralized loan obligation (CLO) market...

Lincoln Educational Faces Investor Lawsuit Over Revenue Drop

Investors Face Rough Waters Okay, let’s dive into this latest mess at Lincoln Educational Services Corp. (NASDAQ:LINC). Things aren't smelling too rosy over at their headquarters. If you've got shares here, you’ll know what I mean. Back in early May, the folks running Lincoln threw a garden party talking up a 19.5% growth in student starts. Who wouldn’t get behind...

Investor Yazan Al Homsi Backs Arcanus Aerial for $500K

Yazan Al Homsi Backs Canadian Innovation Every once in a while, you see a move in the market that feels bigger than the numbers on the page. That's what this $500,000 from Yazan Al Homsi into Arcanus Aerial Systems does. Al Homsi, a UAE-based investor with a solid pedigree, decided to pump half a million bucks into Arcanus just as it's setting down roots in Canadian soil...

Swanson Nexus Pro Launch: Boost for Dietitians

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Leviton Ignites Bridgestone Arena's Modern Makeover

A Power Play in Technology: Leviton's Big Move Forget your lazy Sunday strolls, the latest buzz is all about connectivity at sports arenas. Leviton, the century-old stalwart in networking and electrical solutions, has just tied the knot with the Nashville Predators to electrify Bridgestone Arena. This ain't just a handshake deal; it's a calculated step to transform how...

Innventure Faces Chaotic Legal Storm Over DarkNX Scandal

Innventure's DarkNX Project: From Boon to Bane The stock market is no stranger to seismic shifts, but Innventure, Inc.'s recent plunge is a testament to the catastrophic impact missteps can unleash. This whole DarkNX debacle feels more like a meticulous car wreck than a business evolution. Unpacking the Allegations Sitting comfortably under the NASDAQ:INV ticker,...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Qatar's Cultural Ventures Go Big Through 2030

Cultural Partners Lined Up Well Ahead In the swirling world of cultural diplomacy, Qatar's got its eyes set way beyond the skyline with their Years of Culture initiative. Announced recently, they've lined up partners through 2030, locking hands with Italy, the Netherlands, Switzerland, Portugal, and Spain in the coming years. Such moves aren't just for show—they’re...

Advocacy for Hiring Disabled Kidney Patients Gains Steam

Making Jobs Accessible for Kidney Patients Well, things are stirring up on Capitol Hill, and it's high time, if you ask me. The American Association of Kidney Patients (AAKP) is rallying hard for a bipartisan bill that could change the landscape for folks grappling with kidney diseases and disabilities. You’ve got Reps Pete Sessions and Steny Hoyer pushing this American...

Amy Johnson Steps Up as GDIT President Amid Shifts

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...